Purchases and Sales Made in Q4 2021 in Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB) during Q4 2021. The information is specifically focused on institutions that hold shares of PharmaCyte Biotech, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Shay Capital LLC
New York, NY |
BUY
|
- |
648K+ 4434.69% |
$1.55M - $2.07M
|
662K
$1.04M
|
|
|
Feb 14, 2022
Q4 2021
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
614KNew |
$1.47M - $1.96M
|
614K
$963K
|
|
|
Jan 31, 2022
Q4 2021
|
Equitec Proprietary Markets, LLC
|
BUY
|
- |
259KNew |
$621K - $825K
|
259K
$406K
|
|
|
Feb 14, 2022
Q4 2021
|
Sabby Management, LLC
Upper Saddle River, NJ |
BUY
|
- |
208K+ 20.56% |
$498K - $663K
|
1.22M
$1.91M
|
|
|
Feb 14, 2022
Q4 2021
|
Anson Funds Management LP
Dallas, TX |
BUY
|
- |
193KNew |
$464K - $617K
|
193K
$304K
|
|
|
Feb 11, 2022
Q4 2021
|
Ayrton Capital LLC
Westport, CT |
BUY
|
- |
153KNew |
$368K - $488K
|
153K
$240K
|
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
66.8K+ 4950.63% |
$160K - $213K
|
68.1K
$107K
|
|
|
Feb 11, 2022
Q4 2021
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
37K+ 79.31% |
$88.7K - $118K
|
83.6K
$131K
|
|
|
Feb 08, 2022
Q4 2021
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
35.5KNew |
$85.1K - $113K
|
35.5K
$55.7K
|
|
|
Feb 14, 2022
Q4 2021
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
13.5KNew |
$32.4K - $43.1K
|
13.5K
$21.2K
|
|
|
Feb 10, 2022
Q4 2021
|
Jump Financial, LLC
Chicago, IL |
BUY
|
- |
10.3KNew |
$24.7K - $32.9K
|
10.3K
$16.2K
|
|
|
Feb 14, 2022
Q4 2021
|
Aspire Private Capital, LLC
|
BUY
|
- |
400+ 100.0% |
$960 - $1.28K
|
800
$1.26K
|
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
BUY
|
- |
260+ 7.64% |
$624 - $829
|
3.66K
$5.75K
|
|
|
Feb 14, 2022
Q4 2021
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
101+ 388.46% |
$242 - $322
|
127
$199
|
|
|
Mar 10, 2022
Q4 2021
|
Comprehensive Financial Consultants Institutional, Inc.
Bloomington, IN |
BUY
|
- |
14New |
$33.6 - $44.7
|
14
$22
|
|
|
Jan 31, 2022
Q4 2021
|
Cwm, LLC
|
BUY
|
- |
1New |
$2.4 - $3.19
|
1
$1.57
|
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 16, 2022
Q4 2021
|
Harbour Investments, Inc.
Madison, WI |
SELL
|
- |
-3Closed |
$7.2 - $9.57
|
0
$0
|
|
|
Feb 09, 2022
Q4 2021
|
Charter Oak Capital Management, LLC
|
SELL
|
- |
-20Closed |
$48 - $63.8
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-564- 85.2% |
$1.35K - $1.8K
|
98
$154
|
|
|
Feb 14, 2022
Q4 2021
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-4.76K- 9.57% |
$11.4K - $15.2K
|
44.9K
$70.6K
|
|
|
Feb 14, 2022
Q4 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-6.42K- 90.81% |
$15.4K - $20.5K
|
650
$1.02K
|
|
|
Feb 07, 2022
Q4 2021
|
North Rock Partners, LLC
|
SELL
|
- |
-37.2KClosed |
$89.2K - $119K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-55.5K- 41.54% |
$133K - $177K
|
78.1K
$123K
|
|
|
Feb 14, 2022
Q4 2021
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-57.8K- 65.53% |
$139K - $184K
|
30.4K
$47.7K
|